The DOI matches its Crossref record.
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
Open accessAbstract
A new adenocarcinoma classification was recently introduced by a joint working group of the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society (ERS). A distinction is made between pre-invasive lesions, and minimally invasive and invasive adenocarcinoma. The confusing term “bronchioloalveolar carcinoma” is not used any more and new subcategories include adenocarcinoma in situ and minimally invasive adenocarcinoma. Due to a renewed interest in screen-detected nodules and early-stage lung cancers of <2 cm, this classification also has profound implications for thoracic surgeons. In this article, surgical topics are discussed: the role of a minimally invasive approach, especially video-assisted thoracic surgery, limited resection for early-stage lung cancer, the extent of lymph node dissection, the accuracy of intraoperative frozen section analysis, management of multiple lung nodules and prognostic factors in operated patients. Specific key issues are presented based on the current evidence and areas of surgical uncertainty are defined providing a basis for further studies. Thoracic surgeons will play a major role in the application and global introduction of this new adenocarcinoma classification. The remaining controversies regarding the precise diagnosis and management of early-stage lesions will have to be resolved by multidisciplinary and international collaboration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017161659 · Cited by 2,491
Self-citationVansteenkiste, J., Crinò, L., Dooms, C., Douillard, J. Y., Faivre-Finn, C., Lim, E., Rocco, G., Senan, S., Van Schil, P., Veronesi, G., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu089 · Cited by 493
Self-citationSpecial Treatment Issues in Non-small Cell Lung Cancer
Kozower, B. D., Larner, J. M., Detterbeck, F. C., & Jones, D. R. (2013) · Chest · doi:10.1378/chest.12-2362 · Cited by 372
Asamura, H., Hishida, T., Suzuki, K., Koike, T., Nakamura, K., Kusumoto, M., Nagai, K., Tada, H., Mitsudomi, T., Tsuboi, M., et al. (2013) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.12.047 · Cited by 346
Self-citationAdenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies
Succony, L., Rassl, D., Barker, A., McCaughan, F., & Rintoul, R. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102237 · Cited by 342
Metadata
- Authors
- Van Schil, P. E., Asamura, H., Rusch, V. W., Mitsudomi, T., Tsuboi, M., Brambilla, E., & Travis, W. D.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2011-08-04
- Volume
- 39
- Issue
- 2
- Pages
- 478-486
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2161087401
- Cited by
- 170
- References
- 0
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. https://app.cochat.ai/papers/10.1183/09031936.00027511
- The paper
- Van Schil, P. E., Asamura, H., Rusch, V. W., Mitsudomi, T., Tsuboi, M., Brambilla, E., & Travis, W. D. (2012). Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. European Respiratory Journal. https://doi.org/10.1183/09031936.00027511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.